Reducing test cost through the use of digital testers for analog tests

2006 ◽  
Author(s):  
J. Sweeney ◽  
A. Tsefrekas
Keyword(s):  
Test Cost ◽  
Analog Tests

Reduced-Pin-Count BOST for Test-Cost Reduction

2021 ◽  
pp. 1-1
Author(s):  
Youngkwang Lee ◽  
Young-woo Lee ◽  
Sungyoul Seo ◽  
Sungho Kang
Keyword(s):  
Cost Reduction ◽  
Test Cost ◽  
Test Cost Reduction

scholarly journals Identifying the Optimal Subsets of Test Items through Adaptive Test for Cost Reduction of ICs

Electronics ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 680
Author(s):  
Huaguo Liang ◽  
Jinlei Wan ◽  
Tai Song ◽  
Wangchao Hou
Keyword(s):  
Integrated Circuits ◽  
Cost Reduction ◽  
Bayesian Model ◽  
Test Methods ◽  
Test Time ◽  
Test Quality ◽  
Test Cost ◽  
Test Items ◽  
Adaptive Test ◽  
Test Escapes

With the growing complexity of integrated circuits (ICs), more and more test items are required in testing. However, the large number of invalid items (which narrowly pass the test) continues to increase the test time and, consequently, test costs. Aiming to address the problems of long test time and reduced test item efficiency, this paper presents a method which combines a fast correlation-based filter (FCBF) and a weighted naive Bayesian model which can identify the most effective items and make accurate quality predictions. Experimental results demonstrate that the proposed method reduces test time by around 2.59% and leads to fewer test escapes compared with the recently adopted test methods. The study shows that the proposed method can effectively reduce the test cost without jeopardizing test quality excessively.

Hygro-mechanical modeling of restrained ring test: COST TU1404 benchmark

2019 ◽  
Vol 229 ◽  
pp. 116543 ◽  
Author(s):  
Vít Šmilauer ◽  
Petr Havlásek ◽  
Tobias Gasch ◽  
Arnaud Delaplace ◽  
David E.-M. Bouhjiti ◽  
...  
Keyword(s):  
Ring Test ◽  
Mechanical Modeling ◽  
Test Cost ◽  
Restrained Ring Test ◽  
Restrained Ring

Design Model Research of Software Testing Case Based on Requirement Characteristics

2014 ◽  
Vol 513-517 ◽  
pp. 1621-1624
Author(s):  
Zhi Jian Diao
Keyword(s):  
Software Quality ◽  
Technology Development ◽  
Quality Level ◽  
Test Case ◽  
Application Layer ◽  
Test Cost ◽  
Model Research ◽  
Development Technology ◽  
Multiple Characteristics ◽  
Testing Case

with the computer technology development, software expands the application layer and shows the multiple characteristics of requirement. In recent years, the summarized scale of software system obtains the development and the development technology becomes complicated. Under this condition, software quality receives more attention. The accepted route can distinct the software quality level. Moreover, the created relative use cases will promote the test. Therefore, develop the test automatic layer can decrease the test cost, increase the software summarization quality. We can explore the test case, create the schema, and build the available model.

Concurrent Core Test Based on Partial Test Set Reusing

2014 ◽  
Vol 529 ◽  
pp. 359-363
Author(s):  
Xi Lei Huang ◽  
Mao Xiang Yi ◽  
Lin Wang ◽  
Hua Guo Liang
Keyword(s):  
Minimum Size ◽  
Application Time ◽  
Logical Circuit ◽  
Test Set ◽  
Test Cost ◽  
Test Application ◽  
Sharing Strategy ◽  
Data Volume ◽  
Set Sharing ◽  
Test Sets

A novel concurrent core test approach is proposed to reduce the test cost of SoC. Before test, a novel test set sharing strategy is proposed to obtain a minimum size of merged test set by merging the test sets corresponding to cores under test (CUT).Moreover, it can be used in conjunction with general compression/decompression techniques to further reduce test data volume (TDV). During test, the proposed vector separating device which is composed of a set of simple combinational logical circuit (CLC) is designed for separating the vector from the merged test set to the correspondent test core. This approach does not add any test vector for each core and can test synchronously to reduce test application time (TAT). Experimental results for ISCAS’ 89 benchmarks have been rproven the efficiency of the proposed approach.

Abstract P241: One-Year Cost-Effectiveness of Cytochrome P450 2C19 Genotype-Guided Antiplatelet Therapy in Patients With Acute Coronary Syndromes

2011 ◽  
Vol 4 (suppl_1) ◽  
Author(s):  
Scott L Charland ◽  
Barnabie C Agatep ◽  
Daniel C Malone ◽  
Eric J Stanek
Keyword(s):  
Cytochrome P450 ◽  
Cost Effectiveness ◽  
Antiplatelet Therapy ◽  
Annual Cost ◽  
Extensive Metabolizers ◽  
Cyp2c19 Genotype ◽  
Event Management ◽  
Test Cost ◽  
Cytochrome P450 2C19 ◽  
The Cost

OBJECTIVES: Cytochrome P450 2C19 (CYP2C19) genotype has been shown to affect cardiovascular (CV) outcomes for clopidogrel but not prasugrel. This study evaluates the cost-effectiveness of CYP2C19-guided vs. routine antiplatelet therapy in ACS patients. METHODS: We constructed a literature-based, decision analytic, Markov model (TreeAge 2009) to estimate the cost-effectiveness of CYP2C19-guided aspirin plus either clopidogrel or prasugrel therapy vs. no genotyping. Post-initial ACS CV events were based on the TRITON-TIMI 38 study and related costs were derived primarily using 2007 Healthcare Cost and Utilization Project DRGs for nonfatal MI and stroke, CV death, intracranial hemorrhage, other life-threatening bleed, and minor bleed. Additional costs and disease-state utilities were obtained from other published sources. All costs were adjusted to 2009 $US using the Consumer Price Index medical care component. The model allowed for clopidogrel/prasugrel discontinuation and aspirin monotherapy. Model sensitivity was assessed using 1-way and multi-way analysis of influential parameters. RESULTS: The base case model demonstrated that CYP2C19 genotype guided antiplatelet therapy yielded lower overall annual cost and greater efficacy vs. no genotyping ( Table ). The model was sensitive to (in declining order): clopidogrel cost/day ($1 to $5.78), prasugrel cost/day ($4.09 to $ 6.81), % CYP2C19 extensive metabolizers on clopidogrel (60% to 100%), CYP2C19 test cost ($60 to $250), and monthly CV event management cost. A threshold value for clopidogrel at <$2.14/day favored the no genotyping strategy. However, the genotyping strategy was dominant when clopidogrel cost =$1/day and a CYP2C19 test cost threshold of <$125 on 2-way analysis. CONCLUSIONS: CYP2C19 genotype-guided clopidogrel or prasugrel therapy is cost-effective for up to 1 year in ACS patients, and can remain a preferred strategy at a hypothetical generic clopidogrel cost of $1.00/day. Table Strategy1 Annual Cost Incremental Cost Quality Adjusted Life Year (QALY) Incremental QALY Cost/QALY Incremental Cost Effectiveness (ICER) CYP2C19 Genotype-Guided $ 3,211 0.7212 $ 4,452 No Gentoyping $ 3,331 $120 0.6767 - (0.0445) $ 4,921 (Dominated) 1Base case values:Drug wholesale acquisition cost/day: clopidogrel $4.62, prasugrel $5.45; Baseline post-ACS utility = 0.83; Monthly cost for post-CV event management = $351; CYP2C19 genotyping =$185; After genotyping: 80% of extensive metabolizers, 20% of intermediate metabolizers and 10% of poor metabolizers on clopidogrel; 80% on clopidogrel without genotyping; Willingness to pay = $200

Reliable test architecture with test cost reduction for systolic based DNN accelerators

2021 ◽  
pp. 1-1
Author(s):  
Muhammad Ibtesam ◽  
Umair Saeed Solangi ◽  
Jinuk Kim ◽  
Muhammad Adil Ansari ◽  
Sungju Park
Keyword(s):  
Cost Reduction ◽  
Test Cost ◽  
Reliable Test ◽  
Test Cost Reduction ◽  
Test Architecture
Sign in / Sign up

Export Citation Format

Share Document